Cyclooxygenase-2 expression in cervical intraepithelial neoplasia

Ann N Y Acad Sci. 2009 Aug:1171:111-5. doi: 10.1111/j.1749-6632.2009.04724.x.

Abstract

To evaluate the role of cyclooxygenase (COX)-2 during cervical carcinogenesis, we investigated COX-2 expression in the dysplastic epithelium and stromal cells of cervical intraepithelial neoplasia (CIN). Immunohistochemical analysis with COX-2 antibody was performed on 148 paraffin-embedded tissue specimens of patients who were diagnosed as CIN in our institute. COX-2 expression was evaluated separately in the dysplastic epithelium and stromal cells of CIN. The relationships between COX-2 expression and clinicopathologic variables were examined. For the dysplastic epithelium, COX-2 expression was negative in 137 (92.6%) and positive in 11 (7.4%) specimens. For the stromal cells, COX-2 expression was negative in all specimens. The COX-2 expression in dysplastic epithelium was higher in older (P= 0.038) or postmenopausal (P= 0.025) women. In conclusion, COX-2 expression was observed only in the dysplastic epithelium but not in the stromal cells of CIN. The COX-2 expression in dysplastic epithelium was associated with age and menopausal status.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cyclooxygenase 2 / metabolism*
  • Epithelium / enzymology
  • Epithelium / pathology
  • Female
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Postmenopause
  • Premenopause
  • Stromal Cells / enzymology
  • Stromal Cells / pathology
  • Uterine Cervical Dysplasia / enzymology
  • Uterine Cervical Dysplasia / pathology*
  • Uterine Cervical Neoplasms / enzymology
  • Uterine Cervical Neoplasms / pathology*

Substances

  • Cyclooxygenase 2
  • PTGS2 protein, human